OPEN Foundation

T. Froese

The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action

Abstract

Serotonergic agonist psilocybin is a psychedelic with antidepressant potential. Sleep may interact with psilocybin’s antidepressant properties like other antidepressant drugs via induction of neuroplasticity. The main aim of the study was to evaluate the effect of psilocybin on sleep architecture on the night after psilocybin administration. Regarding the potential antidepressant properties, we hypothesized that psilocybin, similar to other classical antidepressants, would reduce rapid eye movement (REM) sleep and prolong REM sleep latency. Moreover, we also hypothesized that psilocybin would promote slow-wave activity (SWA) expression in the first sleep cycle, a marker of sleep-related neuroplasticity. Twenty healthy volunteers (10 women, age 28-53) underwent two drug administration sessions, psilocybin or placebo, in a randomized, double-blinded design. Changes in sleep macrostructure, SWA during the first sleep cycle, whole night EEG spectral power across frequencies in non-rapid eye movement (NREM) and REM sleep, and changes in subjective sleep measures were analyzed. The results revealed prolonged REM sleep latency after psilocybin administration and a trend toward a decrease in overall REM sleep duration. No changes in NREM sleep were observed. Psilocybin did not affect EEG power spectra in NREM or REM sleep when examined across the whole night. However, psilocybin suppressed SWA in the first sleep cycle. No evidence was found for sleep-related neuroplasticity, however, a different dosage, timing, effect on homeostatic regulation of sleep, or other mechanisms related to antidepressant effects may play a role. Overall, this study suggests that potential antidepressant properties of psilocybin might be related to changes in sleep.

Dudysová, D., Janků, K., Šmotek, M., Saifutdinova, E., Kopřivová, J., Bušková, J., Mander, B. A., Brunovský, M., Zach, P., Korčák, J., Andrashko, V., Viktorinová, M., Tylš, F., Bravermanová, A., Froese, T., Páleníček, T., & Horáček, J. (2020). The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action. Frontiers in pharmacology, 11, 602590. https://doi.org/10.3389/fphar.2020.602590

Link to full text

A role for enhanced functions of sleep in psychedelic therapy?

After a hiatus of several decades, there has been a resurgence of studies into the therapeutic potential of serotonergic psychedelics. When administered in controlled settings, they have been reported to induce a wide variety of long-lasting positive psychological changes. However, the mechanisms by which psychedelics impart these long-lasting benefits remain poorly understood. Here, we highlight one possibility that has remained underexplored: a beneficial interaction with the self-optimizing functions of sleep.
Froese, T., Leenen, I., & Palenicek, T. (2018). A role for enhanced functions of sleep in psychedelic therapy?. Adaptive Behavior26(3), 129-135. 10.1177%2F1059712318762735
Link to full text

On the Origin of the Genus Psilocybe and Its Potential Ritual Use in Ancient Africa and Europe

Abstract

On the Origin of the Genus Psilocybe and Its Potential Ritual Use in Ancient Africa and Europe. The role of altered states of consciousness in the production of geometric and figurative art by prehistoric cultures in Africa and Europe has been hotly debated. Helvenston and Bahn have tried to refute the most famous hypothesis, Lewis-Williams’ neuropsychological model, by claiming that appropriate visual hallucinations required the ingestion of LSD, psilocybin, or mescaline, while arguing that none of these compounds were available to the cultures in question. We present here mycological arguments that tell another story. A prehistoric worldwide distribution of the mushroom genus Psilocybe, and therefore of psilocybin, is supported by the existence of endemic species in America, Africa, and Europe, the disjunct distribution of sister species, and the possibility of long-distance spore dispersal. It is more difficult to point to instances of actual prehistoric ritual use in Africa and Europe, but there are a growing number of suggestive findings.

Froese, T., Guzmán, G., & Guzmán-Dávalos, L. (2016). On the Origin of the Genus Psilocybe and Its Potential Ritual Use in Ancient Africa and Europe1. Economic Botany, 1-12. http://http://dx.doi.org/10.1007/s12231-016-9342-2
Link to full text

interested in becoming a trained psychedelic-assisted therapist?

Indigenous Talk: Fulni-ô Culture & Jurema - Online Event - Dec 12th